Milestones :: Perspectives :: Research



WHO Director-General’s opening remarks at the G7 Summit – 12 June 2021
12 June 2021
Thank you, Prime Minister Johnson, and greetings to everyone. As Sir Patrick and Melinda have outlined, the pandemic is asking us many questions. We welcome and appreciate the ambition of the 100 days mission – we need bigger, faster, better for the future.

The question that every person on earth is now asking is: how and when will we end this pandemic?
We have the knowledge and tools to do it, including vaccines.

In each of your nations, public health measures in combination with vaccination is driving cases and deaths to the lowest levels since the pandemic began. But around the world, many other countries are now facing a surge in cases – and they are facing it without vaccines.

We are in the race of our lives, but it’s not a fair race, and most countries have barely left the starting line.

Our short-term targets are to vaccinate at least 10% of the population of every country by September, and at least 40% by the end of the year, as you have seen in the joint proposal by the IMF, WHO, WTO and the World Bank. To reach those targets, we need 100 million more doses right now – this month and next month – and 250 million more by September. But we must aim higher.


To truly end the pandemic, our goal must be to vaccinate at least 70% of the world’s population by the time you meet again in Germany next year. This can be done with the support of the G7 and G20, together. To do that, we need 11 billion doses.

We welcome the generous announcements you have made about donations of vaccines. Thank you. But we need more, and we need them faster. Immediate dose donations are vital, ideally through COVAX. But so is scaling up production, including through the use of technology transfer and intellectual property waivers.

There are many other lessons we all must learn about how to keep our nations and our world safer from future pandemics. Above all, at the root of the pandemic is a deficit of solidarity and sharing – of the data, information, resources, technology and tools that every nation needs to keep its people safe.

WHO believes the best way to close that deficit is with an international agreement – a treaty, convention, call it what you will – to provide the basis for improved preparedness, detection and response, and for improved cooperation to identify the origins of new pathogens. And I would like to join Boris in thanking Charles Michel. It would also provide a vital underpinning for a stronger WHO at the centre of the global health architecture.

With 194 Member States and 150 country offices, WHO has a unique global mandate, unique global reach and unique global legitimacy. The pandemic has shown that the world needs the World Health Organization more than ever.

We look to the G7 for your continued support for a stronger WHO, for a safer world. Thank you.



G7 discuss 100 Days Mission to improve readiness for future pandemics
Today (12 June), G7 Leaders will discuss the 100 Days Mission, an ambitious but essential mission to have safe and effective vaccines, therapeutics and diagnostics within 100 days of a future pandemic threat being identified. The UK Government’s Chief Scientific Adviser, Sir Patrick Vallance, and Melinda French Gates will address Leaders at the Carbis Bay Summit, setting out how governments, industry, international organisations and others should work together to speed up the world’s response to future pandemic threats…
The partnership today published its report: the ‘100 Days Mission for diagnostics, therapeutics and vaccines to respond to future pandemic threats’. The report sets out recommendations for governments, industry, international organisations and others, to speed up our response to a future pandemic through research & development and best practice in business as usual and having ‘rules of the road’ to guide international responses in pandemics. The report advises that, through building on the lessons and extraordinary scientific response to COVID-19, the world should aim for the following interventions to be available, safe, effective and affordable within the first 100 days of WHO declaring a pandemic:
:: Vaccines ready to be produced at scale for global deployment;
:: An initial regimen of therapeutics; and,
:: Accurate and approved rapid point of care diagnostic tests…

G7 leaders to agree landmark global health declaration
Published 11 June 2021
:: Leaders will sign-up to Carbis Bay Declaration on health, vowing to take steps to ensure the global devastation caused by coronavirus is never repeated
:: UK will establish a new centre to develop vaccines to prevent zoonotic diseases spreading from animals to humans
:: G7 countries and guests will be joined by Sir Patrick Vallance and Melinda French Gates who will present their ‘100 day mission’ to speed up the time it takes to develop vaccines, treatments and diagnostics

G7 Health Ministers’ Meeting, communique, Oxford, 4 June, 2021
…7. We emphasise the importance of promoting and monitoring equitable global access to safe, effective, quality and affordable vaccines, therapeutics and diagnostics. We affirm support for all existing pillars of the Access to COVID-19 Tools Accelerator (ACT-A), including its COVAX facility. We are committed to addressing the financing needs in global health to support the research, development, manufacturing, and equitable distribution of safe and effective COVID-19 diagnostics, therapeutics and vaccines. We note the intention to conduct a comprehensive strategic review as a basis for a possible adaptation and extension of its mandate to the end of 2022. We commit to supporting COVAX financially, including by encouraging pledges to the facility, including at the COVAX AMC Summit, disbursing as soon as possible, providing in-kind contributions, and coordinating with and using COVAX, which is the key mechanism for global sharing of vaccines to supplement its own direct procurement, to enable the rapid equitable deployment of vaccines. In this regard, we welcome the outcome of the COVAX Advance Market Commitment Summit co-hosted by Japan and Gavi on 2 June. We emphasise our support for global sharing of safe, effective, quality and affordable vaccine doses including working with COVAX when domestic situations permit. We affirm our support for efforts to strengthen supply chains and boost and diversify global vaccine manufacturing capacity, including for the materials needed to produce vaccines, including by sharing risks, and welcome the vaccines technology transfer hub launched by WHO. We recall in this regard the Charter for Equitable Access to COVID-19 Tools and welcome the commitments made in the G7 Foreign and Development Ministers’ equitable access and collaboration statement